A Johnson & Johnson veteran teams up with an entrepreneurial physician to combine the best of patient compliance programs with a comprehensive medicines discount program.
CORNWALL, CT (PRWEB) FEBRUARY 06, 2016
The treatment of chronic illnesses commonly includes the long-term use of pharmacotherapy. Although these medications are effective in combating disease, their full benefits are often not realized because approximately 50% of patients do not take their medications as prescribed. In order to solve this critical issue, a former Johnson & Johnson executive has teamed up with an entrepreneurial physician to combine the best of patient compliance programs with a comprehensive medicines discounts program.
“We could not be more thrilled to have Milligram as part of our portfolio of services for patients with chronic disease…it is a great addition!” said Rick Thomas, CEO of Synergia Opcare.
“Because lack of compliance is so tightly tied to the use of medications, our companies were made to partner…Synergia Opcare and Milligram are going to change how we combat chronic disease forever,” said Bruce Wolf, M.D., Founder of Milligram.
Synergia Opcare, helps increase patient compliance in chronic disease, with the most comprehensive portfolio of tools to assist physicians, hospitals and insurers to more effectively keep their patients on track with their prescribed clinical pathway plan.http://www.synergiaopcare.net
Milligram focuses on transparency in drug pricing. Their aim is to treat price blindness. They do this by helping patients and providers see the lowest price for needed medications at the most convenient pharmacy. Milligram also offers providers alternative medicine options that are more cost effective. http://www.milligram.biz